On Demand: NICE Early Scientific Advice: When, Why, and How!

Have you considered using NICE Scientific Advice (SA) to inform your evidence development, trial design, and/or economic modelling? Are you familiar with the concept of NICE SA, but have no direct experience? Or have you used the process before, but want to learn how to optimise your use of it? Join PRECISIONadvisors on July 26 at 9am EST for a complimentary webinar, as we share our experience with NICE SA in a pragmatic discussion of what it can do for you, and best practices for getting the most from NICE SA.

LEARN MORE

On Demand: NICE Early Scientific Advice: When, Why, and How!2023-11-09T08:06:57-05:00

On Demand: Cell and Gene Therapies – How High Can Prices Go?

This ON24 webinar will discuss how cell and gene therapies can be justifiably priced at different levels. We will explore just how high they can extend and also how we can collectively ensure that patients can access these innovations when they are needed. This discussion will be led by David Carr: Senior Director, Global Pricing and Market Access (PRECISIONadvisors), Richard Macaulay: SVP, Global Pricing and Market Access (PRECISIONadvisors).

LEARN MORE

On Demand: Cell and Gene Therapies – How High Can Prices Go?2023-07-18T19:46:57-04:00

On Demand Webinar – Paying for Prevention? Payer Access Challenges and Solutions for Preventative Gene Therapies

Launching a therapy has become increasingly challenging, with only 34% of launches meeting their year-one goals (Evaluate Pharma, McKinsey). In addition, launches have also become more complex, with additional stakeholders to consider as well as the careful navigation of siloed, enterprise-wide functions and dynamic, fragmented data solutions. Not surprisingly, the path to a successful launch can be very narrow.

LEARN MORE

On Demand Webinar – Paying for Prevention? Payer Access Challenges and Solutions for Preventative Gene Therapies2023-02-20T21:07:39-05:00

Market Access and Commercialization with Greg Gregory

Want to learn more about market access considerations for digital health innovations? Don’t miss PRECISIONadvisors Executive Vice President and Managing Director Greg Gregory as he joins Brown University for their digital health commercialization seminar series on March 9 at 1pm EST for his session “Market Access and Commercialization”.

LEARN MORE

Market Access and Commercialization with Greg Gregory2022-03-09T15:59:34-05:00

On-Demand Webinar: How to speed up patient access to innovation: Strategies to convert early European regulatory approval into optimal reimbursement

In this webinar moderated by PRECISIONadvisor's David Carr, we are joined by European payers and industry representatives from Germany (Frank-Ulrich Fricke), Italy (Fabrizio Gianfrate) and the UK (Benit Maru and Andrew Walker) to take a look at the current regulatory and reimbursement landscape, as well as how different countries have sought and will seek to address the gap in evidence requirements between the EMA and HTA bodies.

LEARN MORE

On-Demand Webinar: How to speed up patient access to innovation: Strategies to convert early European regulatory approval into optimal reimbursement2021-10-05T17:06:24-04:00

On-Demand Webinar: Continuing the Conversation-The Future of Reimbursement for Cell and Gene Therapies

Join us for this webinar, which will bring payer representatives from the UK (Andrew Walker), Germany (Frank-Ulrich Fricke), and Italy (Gianluigi Casadei) alongside an industry representative to discuss how payers will respond to this changing C&GT landscape and how manufacturers can proactively mitigate their strategies.

LEARN MORE

On-Demand Webinar: Continuing the Conversation-The Future of Reimbursement for Cell and Gene Therapies2021-06-22T16:36:34-04:00

On-Demand Webinar: Oncology Care in a Value-Based World

Join us for the webinar Oncology Care in a Value-Based World which will highlight the activities and needs of payers and providers as they strive to deliver high-quality oncology care in a value-based environment. In this presentation, KOLs with market access, population health, and EMR experience will share the ways in which payers and health systems are supporting a value-based approach to oncology through care initiatives, technology, and access to innovative therapies.

LEARN MORE

On-Demand Webinar: Oncology Care in a Value-Based World2021-05-19T14:27:47-04:00

On-demand Webinar: Considerations for Internal Versus External Manufacturing for Developing Cell and Gene Therapies

Manufacturing has been widely recognized as a bottleneck to bring advanced cell and gene therapies to the patients and families in need. The question is, should organizations stay the course internally, or look externally for their manufacturing needs?

LEARN MORE

On-demand Webinar: Considerations for Internal Versus External Manufacturing for Developing Cell and Gene Therapies2020-12-10T10:06:08-05:00